a public good project by the
Synthesis
Company
of California

© 2026

Külli Kingo | doi.page

0 works0 citations0 h-index

Külli Kingo

Tartu University Hospital(EE)University of Tartu(EE)

Publications by Year

Research Areas

Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, melanin and skin pigmentation, Asthma and respiratory diseases, Cytokine Signaling Pathways and Interactions

Most-Cited Works

→ Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis(2016)1,987 cited
→ Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity(2012)1,038 cited
→ Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial(2015)538 cited
→ European consensus statement on phenotypes of pustular psoriasis(2017)423 cited
→ Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants(2017)390 cited
→ Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci(2012)353 cited
→

Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants

(2016)

346 cited

→ Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE)(2014)318 cited

→ Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture(2015)317 cited

→ Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study(2016)302 cited